Full Text (PDF)
Review Article

Management of Angina Pectoris

Simrat Kaur, Krishna Gopal, S.P Subashini, Devendra Kumar

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Cardiovascular Medicine and Surgery 9(1-2):p 21-25, January - June 2023. | DOI: https://doi.org/10.21088/jcms.2454.7123.91-223.3

How Cite This Article:

Krishna Gopal, Simrat Kaur, S.P Subashini, et al./Management of Angina Pectoris/J Cardiovasc Med Surg.2023;9(1-2): 21-25.

Timeline

Received : March 16, 2023         Accepted : April 15, 2023          Published : June 30, 2023

Abstract

Angina pectoris is defined as substernal chest pain, pressure, or discomfort that is typically exacerbated by exertion and/or emotional stress, lasts greater than 30 to 60 seconds, and is relieved by rest and nitroglycerin. There are approximately 10 million people in the United States who have angina, and there are over 500000 cases diagnosed per year. Several studies now show that angina itself is a predictor of major adverse cardiac events. In addition, angina is a serious morbidity that impedes quality of life and should be treated. In the United States, pharmacologic therapy for angina includes β-blockers, nitrates, calcium channel blockers, and the late sodium current blocker ranolazine. In other countries, additional pharmacologic agents include trimetazidine, ivabradine, nicorandil, fasudil, and others. Revascularization is indicated in certain high-risk individuals and also has been shown to improve angina.


References

  • 1.   h t t p s : / / w w w . m a y o c l i n i c . o r g / d i s e a s e s -conditions/angina/diagnosis-treatment/drc-20369378
  • 2.   https://en.wikipedia.org/wiki/Angina
  • 3.   https://www.cedars-sinai.org/health-library/diseases-and-conditions/w/what-is-anginapectoris.html
  • 4.   h t t p s : / / j o u r n a l s . s a g e p u b . c o m / d o i /full/10.1177/1074248416679733

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Krishna Gopal, Simrat Kaur, S.P Subashini, et al./Management of Angina Pectoris/J Cardiovasc Med Surg.2023;9(1-2): 21-25.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
March 16, 2023 April 15, 2023 June 30, 2023

DOI: https://doi.org/10.21088/jcms.2454.7123.91-223.3

Keywords

AnginaVariantAtherosclerosisObesityStressElectrocardiogram

Article Level Metrics

Last Updated

Monday 28 September 2026, 16:10:01 (IST)


1823

Accesses

6
242
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 16, 2023
Accepted April 15, 2023
Published June 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share